Matthew E. Levy - Helix | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 8 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

XBB.1.5 Mrna COVID-19 Vaccine Protection Against Inpatient or Emergency Department Visits among Adults Infected with SARS-CoV-2 JN.1 and XBB-lineage Variants

Frontiers in immunology (2025): 1470609-1470609

Cited0Views0WOSBibtex

Reduced Likelihood of Hospitalization with the JN.1 or HV.1 SARS-CoV-2 Variants Compared to the EG.5 Variant

JOURNAL OF INFECTIOUS DISEASESno. 5 (2024): 1197-1201

Cited0Views0WOSBibtex

Influence of BMI-associated Genetic Variants and Metabolic Risk Factors on Weight Loss with Semaglutide: a Longitudinal Clinico-Genomic Cohort Study

Matthew E. Levy,Natalie Telis,Kelly M. Schiabor Barrett,Alexandre Bolze,Douglas Stoller, Christopher N. Chapman,C. Anwar A. Chahal,Daniel P. Judge, Douglas A. Olson,Joseph J. Grzymski,Nicole L. Washington,William Lee,Elizabeth T. Cirulli

crossref（2024）

Cited0Views0Bibtex

A Novel Method for Predicting Lp(a) Levels from Routine Outpatient Genomic Testing Identifies Those at Risk of Cardiovascular Disease Across a Diverse Cohort

Natalie Telis,Hang Dai,Ashley A Waring, David Kann, Dana E. Wyman,Simon White, Basil Khuder,Francisco Tanudjaja,Alexandre Bolze,Matthew E. Levy,Catherine Hajek,Lisa M. McEwen,Douglas Stoller, Christopher N. Chapman,C. Anwar A. Chahal,Daniel P. Judge, Douglas A. Olson,Joseph J. Grzymski,Nicole L. Washington,William Lee,Elizabeth T. Cirulli,Shishi Luo,Kelly M. Schiabor Barrett

crossref（2024）

Cited0Views0Bibtex

Viral SARS-CoV-2 Rebound Rates in Linked Commercial Pharmacy-Based Testing and Health Care Claims

Scott P. Kelly,Lisa M. McEwen,Magnus Isaksson, Sarah Murphy,Simon White,Matthew E. Levy,John T. Mccrone,Geraint Levan, Sharad Santhanam,Mary Lynn Baniecki,Candace Bramson,Heather Rubino, Vicky Hendrick,Holly Soares,Jennifer Hammond,Shishi Luo

OPEN FORUM INFECTIOUS DISEASESno. 6 (2024)

Cited0Views0WOSBibtex

Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Antiviral Prescribing Gaps among Nonhospitalized High-Risk Adults

CLINICAL INFECTIOUS DISEASESno. 6 (2024): 1531-1535

Cited4Views0WOSBibtex

Proportion of Hospitalizations Preventable with Increased Oral SARS-CoV-2 Antiviral Treatment

Matthew E. Levy,Vanessa Chilunda,Phillip R. Heaton,Joseph Grzymski,Pamala A. Pawloski,Jason D. Goldman,Shishi Luo

medrxiv（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn